From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Psychiatry>
  4. Summary and Comment

This Is Your Brain on Drugs: The Marijuana-Psychosis Connection Revisited

In this German population-based study, cannabis use clearly increased the risk for any psychotic symptom.

Some studies have suggested cannabis use as a risk factor for psychosis, but these studies failed to control for predisposition to psychosis and other confounders. In a German population-based study, researchers used personal interviews at baseline and 4 years later to examine the effects of marijuana use in 2437 young subjects (age range, 14-24). Prevalence of lifetime cannabis use (at least 5 times) was 13% at baseline and 15% at follow-up. Lifetime incidence of one psychotic symptom (based on the Composite International Diagnostic Interview) at follow-up was 17% and incidence of at least two symptoms was 7%. Researchers adjusted results for self-reported psychoticism and paranoia scores at baseline ("psychotic predisposition"), demographics, head-trauma history, and use of other drugs and alcohol.

In a logistic-regression analysis, cannabis use significantly increased risk for any psychotic symptom, with a clear dose-response effect. Psychotic predisposition significantly increased this risk, which was greater in subjects with at least two psychosis symptoms than in those with one symptom. The population-attributable risk (proportion of cases that could be avoided by eliminating the risk factor) was 6% overall and 14% for participants with psychotic predisposition.

Comment: Cannabis use clearly increased the risk for any psychotic symptom; having more symptoms, psychotic predisposition, or more frequent cannabis use strengthened this association. These findings are consistent with cannabis effects on increasing dopamine release in the frontal lobe, with the increase in cannabinoid receptors in schizophrenic brains, and with increased levels of endogenous cannabinoids in the spinal fluid of schizophrenic individuals. Given the minimal level of psychotic symptoms examined in this study, its findings may pertain more to schizophrenic-spectrum and atypical-psychotic conditions than to more narrowly defined schizophrenia.

— Peter Roy-Byrne, MD

Published in Journal Watch Psychiatry January 27, 2005

Citation(s):

Henquet C et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005 Jan 1; 330:11. http://bmj.bmjjournals.com/cgi/content/full/330/7481/11

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2005. Massachusetts Medical Society. All rights reserved.